Table of Contents
Introduction
Midodrine is a prodrug used in the treatment of symptomatic orthostatic hypotension. It works by increasing vascular tone through selective stimulation of alpha-1 adrenergic receptors after being metabolized into its active form, desglymidodrine.
Step-by-Step Mechanism of Action
- Prodrug Conversion
After oral administration, midodrine is rapidly converted in the liver and systemic circulation into its active metabolite, desglymidodrine. - Selective α1-Adrenergic Agonism
Desglymidodrine selectively stimulates peripheral alpha-1 adrenergic receptors, primarily on arteriolar and venous smooth muscle. - Vasoconstriction
Activation of these receptors causes vasoconstriction, increasing peripheral vascular resistance. - Elevation of Blood Pressure
As a result of vasoconstriction, systolic and diastolic blood pressure increase, particularly beneficial in the upright posture. - Minimal Central Effects
Because midodrine and its active metabolite poorly cross the blood-brain barrier, central nervous system side effects are minimal.

Pharmacokinetic Parameters
Parameter | Value |
---|---|
Route | Oral |
Bioavailability | Approximately 93% |
Active Form | Desglymidodrine |
Tmax | 1–2 hours |
Half-life | 3–4 hours (desglymidodrine) |
Metabolism | Hepatic and systemic |
Excretion | Renal (primarily as active metabolite) |
Clinical Uses
- Symptomatic orthostatic hypotension
- Off-label: Intradialytic hypotension, hepatorenal syndrome (supportive)
Adverse Effects
- Supine hypertension
- Paresthesia
- Piloerection
- Urinary retention
- Pruritus and scalp tingling
Comparative Analysis
Drug | Mechanism | Duration | Comments |
---|---|---|---|
Midodrine | Alpha-1 agonist (peripheral) | 3–4 hours | Oral prodrug with minimal CNS penetration |
Droxidopa | Norepinephrine precursor | ~2–3 hours | Central and peripheral effects |
Fludrocortisone | Mineralocorticoid | Long-acting | Acts via sodium and water retention |
MCQs
- Midodrine is converted into which active metabolite?
a) Noradrenaline b) Desglymidodrine c) Ephedrine d) Dopamine
Answer: b) Desglymidodrine - The main action of midodrine is:
a) Beta-2 stimulation b) Alpha-1 receptor blockade c) Alpha-1 receptor agonism d) Inhibition of norepinephrine uptake
Answer: c) Alpha-1 receptor agonism - Which of the following is a contraindication to midodrine use?
a) Asthma b) Supine hypertension c) Bradycardia d) Anemia
Answer: b) Supine hypertension - Midodrine is used primarily in the treatment of:
a) Tachycardia b) Orthostatic hypotension c) Hypertension d) Heart failure
Answer: b) Orthostatic hypotension - Duration of action of midodrine is approximately:
a) 1 hour b) 3–4 hours c) 8 hours d) 24 hours
Answer: b) 3–4 hours - Midodrine has minimal central nervous effects because:
a) It is metabolized peripherally b) It cannot cross the blood-brain barrier c) It is rapidly degraded d) It acts on dopamine receptors
Answer: b) It cannot cross the blood-brain barrier - Supine hypertension occurs due to:
a) Volume depletion b) Excessive vasodilation c) Unopposed vasoconstriction when lying down d) Beta-blockade
Answer: c) Unopposed vasoconstriction when lying down - Which is NOT a known side effect of midodrine?
a) Goosebumps b) Urinary retention c) Bradycardia d) Tachypnea
Answer: d) Tachypnea - What is the bioavailability of midodrine?
a) 20% b) 50% c) 93% d) 100%
Answer: c) 93% - Midodrine is metabolized mainly in:
a) Kidney b) Lungs c) Liver and plasma d) Pancreas
Answer: c) Liver and plasma
FAQs
1. What is the dosing frequency of midodrine?
Typically administered 2–3 times daily, avoiding late evening doses to prevent supine hypertension.
2. Can it be used in renal impairment?
Use with caution, as the drug is excreted renally and may accumulate.
3. Does midodrine cause tachycardia?
No, it generally has little effect on heart rate.
4. What precautions should be taken when using midodrine?
Blood pressure should be monitored in both supine and standing positions to avoid excessive hypertension.
5. Can it be used with beta-blockers?
Yes, but with caution due to additive effects on blood pressure and possible bradycardia.
References
- DrugBank: Midodrine
- FDA Label: Midodrine HCl
- PubMed: Clinical pharmacology of midodrine
- Drugs.com: Midodrine Monograph
- StatPearls: Midodrine Overview

I am pursuing MBA in pharmaceutical management from NIPER Hyderabad with a strong academic record and proven success in national-level pharmacy entrance exams. I secured AIR 61 in NIPER 2024 (MS/M.Pharm) and AIR 27 in NIPER MBA, along with AIR 147 in GPAT 2024 and AIR 907 in GPAT 2023. I also achieved AIR 6 in AIIMS CRE-2025 for Drug Store Keeper and was selected as a Pharmacist (AIR 61) for ESIC. Additionally, I was the Runner-Up in Round 2 of the EY Case Study Competition.
At PharmacyFreak.com, I aim to guide future pharmacists through expert content, exam strategies, and insightful resources based on real experience and academic excellence.
Mail- harsh@pharmacyfreak.com